These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 15231142

  • 21. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 22. [The effects of treatment with atenolol and benazapril on 24-hour pressure variability].
    Prattichizzo FA, Galetta F.
    Minerva Cardioangiol; 1993 Dec; 41(12):587-90. PubMed ID: 8139779
    [Abstract] [Full Text] [Related]

  • 23. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Dec; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 24. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 25. T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors.
    Yu H, Lin S, Liu G, Zhang Y, Deng C, Ma W.
    Hypertens Res; 2005 Dec; 28(12):981-6. PubMed ID: 16671337
    [Abstract] [Full Text] [Related]

  • 26. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K, Ideishi M, Tashiro T, Morishige N, Yamada T, Saku K, Urata H.
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I.
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [Abstract] [Full Text] [Related]

  • 28. Quantitative study of circadian variations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects.
    Zhao ZY, Zhao ZY, Wang YQ, Yan ZH, Cui J, Li YY.
    Clin Exp Hypertens; 2005 May; 27(2-3):187-94. PubMed ID: 15835381
    [Abstract] [Full Text] [Related]

  • 29. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension.
    Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CR, Muxfeldt ES, Salles GF.
    Hypertens Res; 2009 Jul; 32(7):591-6. PubMed ID: 19444279
    [Abstract] [Full Text] [Related]

  • 30. Linear relationship between systolic and diastolic blood pressure monitored over 24 h: assessment and correlates.
    Gavish B, Ben-Dov IZ, Bursztyn M.
    J Hypertens; 2008 Feb; 26(2):199-209. PubMed ID: 18192832
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [Abstract] [Full Text] [Related]

  • 32. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P, Angeli F, Gattobigio R, Guerrieri M, Benemio G, Porcellati C.
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [Abstract] [Full Text] [Related]

  • 33. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
    Ishikawa J, Kario K, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K, J-MORE Group.
    Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
    [Abstract] [Full Text] [Related]

  • 34. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group.
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [Abstract] [Full Text] [Related]

  • 35. [Conversion enzyme inhibitors in the treatment of elderly hypertension patients].
    Amery A.
    Verh K Acad Geneeskd Belg; 1991 Dec; 53(2):163-85; discussion 185-6. PubMed ID: 1853643
    [Abstract] [Full Text] [Related]

  • 36. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME.
    J Am Coll Cardiol; 2009 Feb 03; 53(5):445-51. PubMed ID: 19179203
    [Abstract] [Full Text] [Related]

  • 37. [Multilevel analysis on influencing factors regarding blood level among elderly hypertensive patients].
    Gao JL, Fu H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr 03; 30(4):318-21. PubMed ID: 19731518
    [Abstract] [Full Text] [Related]

  • 38. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA, Rocchi R, Guidoni A, Mangoni AA.
    Panminerva Med; 2008 Sep 03; 50(3):207-16. PubMed ID: 18927524
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C, Investigators of the ESTEPP Study.
    Int J Clin Pract; 2005 Apr 03; 59(4):478-84. PubMed ID: 15853868
    [Abstract] [Full Text] [Related]

  • 40. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar 03; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.